Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 12/2010

01-12-2010 | Letter to the Editors

Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery

Authors: Domenico Vitale, Vincenzo De Santis, Fabio Guarracino, Andrea Fontana, Fabio Pellegrini, Luigi Tritapepe

Published in: Clinical Research in Cardiology | Issue 12/2010

Login to get access

Excerpt

Sirs: …
Literature
1.
St André AC, Del Rossi A (2005) Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med 33:2082–2093CrossRef
2.
Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A (2008) Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology 108:979–987CrossRefPubMed
3.
4.
Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807–816CrossRefPubMed
5.
Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, BEAUTIFUL investigators (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372:817–821CrossRefPubMed
6.
Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, New York
7.
Diggle PJ, Liang KY, Zeger SL (1994) Analysis of longitudinal data. Oxford University Press, Oxford
8.
Bollano E, Täng MS, Hjalmarson A, Waagstein F, Andersson B (2003) Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure. Heart 89:621–624CrossRefPubMed
9.
Tarnow J, Komar K (1988) Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade. Anesthesiology 68:912–919CrossRefPubMed
10.
Vatner SF, McRitchie RJ, Braunwald E (1974) Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. J Clin Invest 53:1265–1273CrossRefPubMed
11.
Link A, Reil JC, Selejan S, Böhm M (2009) Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure. Clin Res Cardiol 98:513–515CrossRefPubMed
12.
Monnet X, Ghaleh B, Colin P, de Curzon OP, Giudicelli JF, Berdeaux A (2001) Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning. J Pharmacol Exp Ther 299:1133–1139PubMed
13.
Romson JL, Leung JM, Bellows WH et al (1999) Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients. Anesthesiology 91:1318–1328CrossRefPubMed
14.
Metadata
Title
Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery
Authors
Domenico Vitale
Vincenzo De Santis
Fabio Guarracino
Andrea Fontana
Fabio Pellegrini
Luigi Tritapepe
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Clinical Research in Cardiology / Issue 12/2010
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-010-0208-9

Other articles of this Issue 12/2010

Clinical Research in Cardiology 12/2010 Go to the issue

Original Paper

Elevated level of ADAMTS4 in plasma and peripheral monocytes from patients with acute coronary syndrome

Original Paper

One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

Original Paper

Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease

Original Paper

Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability

Erratum

Erratum to: Cor triatriatum dexter: rare case of neonatal cyanosis

Review

Tako-Tsubo syndrome: dying of a broken heart?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits